Side-by-side comparison of AI visibility scores, market position, and capabilities
Jord BioScience raised $25M in 2025 for biological soil amendments that enhance nitrogen fixation and phosphorus solubilization, reducing synthetic fertilizer use by 20-40% while improving crop yields.
Jord BioScience develops microbial and biochemical soil amendments that enhance the natural processes by which soil bacteria fix atmospheric nitrogen and solubilize soil phosphorus — reducing farmers' dependence on synthetic nitrogen and phosphorus fertilizers. The company's products are applied as seed coatings or in-furrow treatments, delivering targeted microbial communities that colonize the rhizosphere and enhance nutrient availability throughout the growing season.
$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.
ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.